These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 38260726)

  • 1. Advancing genome editing with artificial intelligence: opportunities, challenges, and future directions.
    Dixit S; Kumar A; Srinivasan K; Vincent PMDR; Ramu Krishnan N
    Front Bioeng Biotechnol; 2023; 11():1335901. PubMed ID: 38260726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-guided genome editing in plants using a CRISPR-Cas system.
    Xie K; Yang Y
    Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR Genome Editing Made Easy Through the CHOPCHOP Website.
    Labun K; Krause M; Torres Cleuren Y; Valen E
    Curr Protoc; 2021 Apr; 1(4):e46. PubMed ID: 33905612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing and kidney health.
    Tavakolidakhrabadi N; Aulicino F; May CJ; Saleem MA; Berger I; Welsh GI
    Clin Kidney J; 2024 May; 17(5):sfae119. PubMed ID: 38766272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
    Zhang Y; Karakikes I
    Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics.
    Bhat AA; Nisar S; Mukherjee S; Saha N; Yarravarapu N; Lone SN; Masoodi T; Chauhan R; Maacha S; Bagga P; Dhawan P; Akil AA; El-Rifai W; Uddin S; Reddy R; Singh M; Macha MA; Haris M
    J Transl Med; 2022 Nov; 20(1):534. PubMed ID: 36401282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR genome editing using computational approaches: A survey.
    Alipanahi R; Safari L; Khanteymoori A
    Front Bioinform; 2022; 2():1001131. PubMed ID: 36710911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome editing in sea urchin embryos by using a CRISPR/Cas9 system.
    Lin CY; Su YH
    Dev Biol; 2016 Jan; 409(2):420-8. PubMed ID: 26632489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
    Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
    Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing.
    Chen Y; Ping Y
    Acc Chem Res; 2023 Aug; 56(16):2185-2196. PubMed ID: 37525893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
    Naeem M; Majeed S; Hoque MZ; Ahmad I
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of base editors and prime editors advances precision genome engineering in plants.
    Hua K; Han P; Zhu JK
    Plant Physiol; 2022 Mar; 188(4):1795-1810. PubMed ID: 34962995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
    Bloomer H; Khirallah J; Li Y; Xu Q
    Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R; Lin G; Li J
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.